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Abstract
Surgical percutaneous bone biopsy specimen after a 14-day antibiotic-free period represents the gold standard of care for diabetic
foot osteomyelitis but may be difﬁcult to implement in many institutions. We evaluate a simpliﬁed strategy based on the results of
per-wound bone specimen culture. For that purpose, we retrospectively reviewed the charts of 80 consecutive patients with diabetic
osteomyelitis and bone sample obtained via the wound after a careful debridement. The outcome was deﬁned as favourable if there
was a complete healing of the wound with no sign of infection and stable or improved bone X-ray 6 months after antibiotic therapy
completion. Culture of bone specimens was positive in 96% of patients, although half of the patients did receive a course of antimicro-
bials within 14 days of the bone specimen being obtained. A total of 129 bacterial isolates were obtained from bone cultures with a
mean of 1.6 ± 1 isolates per patient (Staphylococcus aureus: 33%; coagulase-negative staphylococci: 14%; streptococci: 9%; enterococci:
12%; corynebacteria: 4%; Gram-negative bacilli: 20%; anaerobes: 4%). Forty-six percent of cultures were monomicrobial. The mean dura-
tion of follow-up from diagnosis was 17 ± 1 months. Six months after discontinuation of antibiotics, six patients (7.5%) had died, nine
were considered as therapeutic failures and 65 were considered as cured. Fifty-four of these 65 patients had follow-up data available at
1 year and remained in remission. In conclusion, a simpliﬁed procedure based on the culture of bone sample obtained via the ulcer after
a careful debridement of the wound is effective in the medical management of diabetic foot osteomyelitis.
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Diabetic foot osteomyelitis is usually a consequence of a
neglected chronic ulcer, which may produce silent soft tissue
infection with contiguous bone involvement [1]. Exploration
after ulcer debridement may reveal an exposed bone or
joint, which is highly suggestive of osteomyelitis [2]. The clin-
ical suspicion is usually conﬁrmed by radiological investiga-
tions (repeated X-rays, magnetic rsonance imaging or
computed tomography scans) [3,4]. The optimal manage-
ment of diabetic osteomyelitis is still a matter of debate and
there is no universally accepted strategy [5,6]. One radical
option for severe diabetic foot osteomyelitis is surgical
amputation, including total ray, transmetatarsal and limb
amputation [1]. Lower limb amputations are the most dra-
matic complications associated with diabetes and are 12-fold
more frequent in the diabetic population than in the nondia-
betic one [7]. The consequences of amputation are multiple
and include psychosocial issues, nonhealing surgical wounds,
postoperative infection and postural instability with recur-
rent ulceration and further amputation [8]. Accordingly,
efforts have been made to limit amputation to patients with
diabetic foot osteomyelitis [9]. One option is to perform a
conservative surgery without local or high-level amputation,
followed by prolonged antibiotic therapy [10,11]. Some phy-
sicians advocate conservative nonsurgical management of dia-
betic osteomyelitis [8]. In these cases, it is extremely
important to obtain a high-quality specimen for culture and
to administrate a long course (several months) of adequate
antibiotic therapy. Several sampling techniques are used in
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clinical practice. Simple swabbing of the ulcer is often per-
formed but should be proscribed because of inaccurate
results [5]. Kessler et al. [12] advocated the use of needle
aspiration through the normal skin surrounding the foot
ulcer. However, this method was recently shown to be
inconsistent with transcutaneous bone biopsy culture [13].
Deep specimens obtained after wound debridement are usu-
ally recommended but surgical percutaneous bone biopsy is
likely to represent the gold standard method for reliable
identiﬁcation of the causal bacteria [14]. However, because
bone biopsy is an expensive and invasive technique that
requires an experienced surgeon to carry out the proce-
dure, it is difﬁcult to implement in most health care centres
[15]. Furthermore, although Senneville et al. [14] did not
report any side effects with this technique, percutaneous
bone biopsy may compromise wound healing in patients with
arteriopathy and severe neuropathy.
We evaluated a simpliﬁed procedure for the medical man-
agement of severe diabetic foot osteomyelitis with exposed
bone, based on the results of bone sample culture obtained
via the ulcer after a careful debridement of the wound.
Materials and Methods
Setting
Patients were retrospectively recruited at the Diabetic Foot
Infection Day Care Unit of the Hoˆpital Saint Jacques in
Clermont-Ferrand, France, a 742-bed university tertiary care
hospital. Only patients with conﬁrmed or suspected diabetic
foot infection attend the clinic, so the prevalence of osteomy-
elitis was high. Patient data were recorded on dedicated
charts and included medical history, a picture of the wound
with a detailed description of its exploration, the method
used to obtain the microbiological sample, and details of
prescription medications and outpatient wound care.
Patients
Data were abstracted from patients who had been referred to
the Diabetic Foot Infection Day Care Unit from January 2005
to January 2009. After chart review, patients were included in
the study if they fulﬁlled the criteria: (i) clinical signs suggestive
of infection (discharge, swelling, pain, inﬂammation, chronic
nonhealing wound); (ii) positive probe-to-bone test (i.e. this
test is positive when the bone can be felt through a foot ulcer
using a sterile blunt metal probe); (iii) initial or subsequent
X-ray showing signs of osteomyelitis contiguous to the wound
site; (iv) no clinical signs of active Charcot’s disease; (v) bone
sample obtained during attendance at the unit; (vi) no surgery
involving the bone within the ﬁrst week after diagnosis
(i.e. subsequent surgery involving the bone was a criteria deﬁn-
ing treatment failure; see below).
Bone samples
After a careful debridement, the wound was cleaned with
polyvidone iodine and then washed with sterile saline solu-
tion. When bedside bone testing revealed fragments of
infected bone or sequestra, these were removed until
healthy bone was identiﬁed. Bone samples were sent to the
microbiology laboratory within 2 h in a sterile tube with a
few drops of sterile saline solution. When bone testing was
positive but the bone was not perceived as contaminated, a
small sample was harvested and sent to microbiology labora-
tory. All samples were taken by the same operator, who
wore sterile gloves and a gown. A disposable needle holder
was used to harvest the fragment of infected bone.
Microbiology analysis
Aerobic and anaerobic cultures were performed for each
sample for 6 days. Bacterial isolates were identiﬁed at the
species level with the VITEK2 or API Systems (Biome´rieux,
La Balme, France). Antibiotic susceptibility testng was per-
formed using the VITEK2 or API Systems or the disk diffu-
sion method of the Comite´ de l’Antibiogramme de la Socie´te´
Franc¸aise de Microbiologie (Comite´ de l’Antibiogramme de
la Socie´te´ Franc¸aise de Microbiologie, 2009; Communique´
2009). Resistant microorganisms were deﬁned as: for Gram-
negative bacilli, resistance or intermediate susceptibility to
ceftazidime; for staphylococci, resistance to methicillin; and,
for enterococci, resistance to vancomycin.
Management
Patients are usually referred to our unit by the general practi-
tioner or a nurse, when they are asked to stop any antibiotic
therapy until attending the unit. Bone samples were taken at
the unit (see below) after clinical assessment. When osteomy-
elitis was associated with severe deep soft tissue infections or
systemic signs of infection, the patient was hospitalized and an
intravenous empirical antibiotic therapy (a combination of
high-dose amoxicillin–clavulanic acid and levoﬂoxacin when
there was no risk of multiresistant bacteria and piperacillin-ta-
zobactam plus teicoplanin when a multiresistant bacteria had
been previously found in the wound) was started when await-
ing bone samples. Other patients received oral or intravenous
home therapy. Antibiotic therapy was adjusted according to
the culture results to enable use of the antimicrobial with the
narrowest effective spectrum. Oral antibiotic therapy con-
sisted of a combination of drugs with high oral absorption and
good penetration of bone, mainly rifampicin, fusidic acid, levo-
ﬂoxacin, clindamycin and trimethoprim/sulphamethoxazole.
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Amoxicillin–clavulanic acid was used when cultures showed
susceptible mixed bacteria. Outpatient intravenous antibiotic
therapy consisted mainly of teicoplanin, ceftriaxone or a
continuous infusion of ceftazidime or piperacillin–tazobactam,
and was used in cases of resistant bacteria or poor patient
adherence to oral therapy.
Data recording
The following data were recorded after chart review: demo-
graphic data; prior history of hospitalization, amputation or
osteomyelitis; location and description of the wound; joint
and bone infected on X-ray with subsequent development;
antibiotic therapy before bone sampling; need for surgery for
abscess drainage. The outcome was deﬁned as favourable if
there was a complete healing of the wound with no signs of
infection and stable or improved bone X-ray, 6 months after
the completion of antibiotic therapy. Outcome was also
assessed 1 year after antibiotic completion for patients
whose treatment ﬁnished before September 2008. For
patients who did not attend our clinic during the follow-up
period required by the study, the general practitioner and
patient were contacted by phone to conﬁrm favourable out-
comes. Other outcomes were deﬁned as failure and were
classiﬁed as amputation (for any cause), relapse (new episode
of infection at the same or a contiguous site during follow-
up, whatever the microbial cause), persistent infection (no
response to the antibiotic therapy active against the organ-
isms found in bone culture) and stability (if the wound was
not healed at 6 months but fulﬁlled other criteria for favour-
able outcome).
Statistical analysis
For univariate analysis, chi-square or Fisher’s exact test were
used for comparisons between categorical variables. For mul-
tivariate analysis, a logistic stepwise backward regression was
used. Categorical variables with p <0.1 on univariate analysis
were used as candidate variables for multivariate analysis.
Statistical analysis was performed using SPSS software, version
10.1 (SPSS, Inc., Chicago, IL, USA).
Results
Patients
From January 2005 to January 2009, 80 patients met the
inclusion criteria. Most patients were diagnosed in 2007 and
2008 (35% and 36%, respectively).The mean age was 68 ± 1
(range 39–89) years and 84% were men. Other patients
characteristics are shown Table 1. Of the 49 patients with
peripheral arteritis, 26 had angioplasty and 11 underwent
vascular surgery; there was no possibility of revascularization
for the others. Of the patients, 37.5% had a past history of
amputation as a result of vascular (16%), infectious (9%) or
mixed (12.5%) causes. Amputation involved the ﬁrst toe for
11%, other toes for 22.5%, the fore-foot for 2.5% and the limb
for 2.5%. Of the patients, 47.5% had a history of hospitalization
within 3 months before the bone sample was obtained.
In 49% of cases, the infection involved a metatarsophalan-
geal (MTP) joint (Table 1). Seven (9%) had a calcaneum infec-
tion and ten (8%) had osteomyelitis after amputation
because of arteritis. Twenty-one percent had visible, exposed
bone or joint on physical examination. Fifteen patients had
bone specimens sent for histology, which showed compatibil-
ity with an infectious process. Only one patient (the only
one who did not have any neuropathy) required a painkiller
(morphine sulphate, 5 mg) before the bone specimen was
drawn.
Microbiological ﬁndings
There were 129 isolates obtained from bone cultures from
the 80 patients, with a mean of 1.6 ± 1 species per patient
(Staphylococcus aureus: 33%; central nervous system: 14%;
streptococci: 9%; enterococci: 12%; corynebacteriae: 4%;
Gram-negative facultative aerobic rods: 12%; Pseudomonas
aeruginosa: 8%; and anaerobes: 4%). Culture of bone speci-
men was positive in 96% of patients (Table 2), although half
(n = 42) of the patients received a course of antimicrobials
within 14 days of bone sampling (Table 1).
Of these 42 patients, 30 had severe deep infection of the
foot and were initially treated by their general practitioners
with a combination of antibiotics (quinolone and rifampicin in
six patients, quinolone and another antibiotic in 15, and a
TABLE 1. Characteristics of the 80 patients with diabetic




Nondialysed chronic renal failure 26%
Dialysis 5%
Past history of osteomyelitis 50%
Past history of amputation 37.5%
Osteoarthritis location
Hallux
Distal phalanx 6% (5)
Interphalangeal joint 5% (4)
Metatarsophalangeal joint 14% (11)
Other toes (second to ﬁfth)
Distal phalanx 7.5% (6)
Interphalangeal joints 19% (15)
Metatarsophalangeal joints 35% (28)
Calcaneum 9% (7)
Other 5% (4)
Course of antibiotic therapy >24 h preceding the bone specimen
Within 3 days 45%
Within 14 days 53%
Within 3 months 72%
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combination of other antibiotics in nine). The 12 remaining
patients received a single antibiotic. Forty-six percent of cul-
tures were monomicrobial. Two bacterial species were
found in 37.5% of bone cultures, three in 11%, and ﬁve in
1%. Two patients (2.5%) had negative cultures: both received
antimicrobial treatment within 3 days before the bone sam-
pling and were successfully treated with a 6-week course of
oral therapy with no relapse after 18 months of follow-up.
Methicillin-resistant S. aureus (MRSA) was the most fre-
quently isolated organism, especially in samples with only
one pathogen (Table 2). There was a signiﬁcant association
between a monomicrobial culture and MRSA (p <0.001).
Other bacteria and prior antibimicrobial therapy were not
associated with monomicrobial culture. Fidty-ﬁve percent of
patients had at least one multiresistant microorganism. Vari-
ables associated with resistance in the univariate analysis are
detailed in Table 3. In multivariate analyses, two variables
were independently predictive for resistance: prior antibiotic
therapy within 14 days (OR 5; 95% CI 2–13; p 0.005) and
arteritis (OR 5; 95% CI 2–16; p 0.002).
Outcome
The mean duration of follow-up from time of specimen col-
lection was 17 ± 1 months. No patient was no lost to fol-
low-up. Thirty percent of patients were hospitalized at the
time of diagnosis for a mean duration of 18 ± 3 days (range
5–54 days). The osteomyelitis was associated with abscess in
14% of patients, of whom two required a surgical drainage
and nine were drained at the Diabetic Infection Day Care
Unit. Antibiotic therapy is shown in Fig. 1. Of the 80
patients, 39% received a course of intravenous antibiotic
therapy for a mean duration of 36 ± 3 days. Of these, 29%
received intravenous antimicrobials as initial therapy and 10%
were started on oral and then switched to intravenous ther-
apy (six because of gastrointestinal irritation and two
TABLE 2. Bacteria found in 80 bone biopsies from the 80









Number of samples 80 76 176
Number of isolates 129 125 204
Mean number of isolates per sample 1.6 ± 1 1.54 –
Number of culture negative samples (%) 2 (2.5%) 2a 20 (11%)
Number (%) of isolates, by pathogen
Gram-positive
Staphylococci 61 (47%) 65 (52%) 117 (57%)
Staphylococcus aureus 43 (33%) 33 (26%) 95 (47%)
MRSA 24 (19%) 12 (10%) 35 (17%)
Central nervous system 18 (14%) 32 (26%) 22 (11%)
Streptococci 12 (9%) 15 (12%) 7 (3%)
Enterococci 15 (12%) 10 (8%) 2 (1%)
Corynebacteriae 5 (4%) 3 (2%) –
Gram-negative bacilli 26 (20%) 23 (18%) 59 (29%)
Pseudomonas aeruginosa 10 (8%) 3 (2%) 18 (9%)
Anaerobes 5 (4%) 6 (5%) –
aNot included in the present study.
TABLE 3. Risk factors associated with resistant bacteria in





isolated (n = 44)
No
resistance
(n = 36) p
Age >70 years 50% 36% NS
Prior antibiotic therapy
Within 3 months 82% 61% 0.04




Arteritis 72 44 0.01
Chronic renal failure 32% 31% NS
History of osteoarthritis 50 50 NS
History of amputation 48% 25% 0.04
NS, not signiﬁcant.
IV only: 15%
IV then oral: 
14%
Oral only: 57%

















FIG. 1. (a) Route of antibiotic therapy prescribed for the treatment
of the 80 patients with diabetic osteomyelitis; ‘oral then IV’ means
that patients were started on oral and then switched to intravenous
therapy (six because of gastrointestinal irritation as a result of oral
antibiotics and two because of unsatisfactory outcome after oral
therapy during follow-up); ‘IV then oral’ means that patients were
switched to oral therapy after a course of 7–14 days of intravenous
therapy. (b) Distribution of the intravenous antimicrobials prescribed
in the 30 patients having received a course of intravenous therapy.
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because of unsatisfactory response). Intravenous treatments
were administrated at the hospital in four patients, at the
hospital then at home in ﬁve, and at home only in 21. The
mean duration of intravenous home therapy was
38 ± 3 days. Of the patients, 57.5% were treated exclusively
with a combination of oral antimicrobials. Three patients did
not receive any antibiotic therapy because of the culture of
multiresistant bacteria and allergy or intolerance to multiple
antimicrobials. They were instead treated with removal of
sequestra or infected bone at the bedside. All these three
patients were considered as cured 6 months after antibiotic
completion. After 1 year of follow-up, all were still relapse-
free but two experienced a new episode of osteomyelitis at
another site.
Of the remaining 77 patients, 34% were treated for
6 weeks, 36% for 9 weeks, and 30% for 12 weeks or more.
At 6 months after antibiotics discontinuation, 7.5% had
died, including ﬁve patients who did not complete their
course of antimicrobials and died within 3 months after the
diagnosis of osteomyelitis. Of these ﬁve patients, four were
considered as being in remission (healed wound and stable
X-ray) during follow-up and osteomyelitis did not contribute
to death; one died from cirrhosis before the end of antibiotic
therapy with an MRSA bacteraemia originating from the bone
infection; and one died 5 months after completion of antibi-
otics and was considered as cured. Of the 74 patients surviv-
ing 6 months after completion of antimicrobial therapy, nine
were considered as failures: two had amputations for vascu-
lar reasons within 3 months of antibiotic completion; two
relapsed after being considered as cured at the 3-month
review; and ﬁve remained stable (including four with calca-
neum infection and severe arteritis and one with osteomyeli-
tis involving several sectioned bones after amputation
because of arteritis). Sixty-ﬁve of 74 patients were consid-
ered as cured 6 months after antibiotic completion; how-
ever, seven experienced a distinct episode of osteomyelitis,
with different locations and causal bacteria from the initial
infection. Follow-up data 1 year after antibiotic completion
were available for 54 of the 65 patients considered as cured
at 6 months: they had neither relapse, nor an amputation.
However, six of the patients had a distinct new episode of
osteomyelitis at a different location.
Discussion
We evaluated a simpliﬁed strategy to manage diabetic osteo-
myelitis, based on culture results of bone samples obtained
via the ulcer after a careful debridement of the wound. The
bone sample was taken even if antibiotics prescribed by the
general practioner before attendance to our clinic had not
been discontinued. Patients received antimicrobials that were
effective against the organisms found in the bone culture.
Cultures were positive in 97.5% of patients and 88% were
considered as cured 6 months after the end of antibiotic
therapy.
Of the 54 patients with follow-up data available 1 year
after completion of antibiotics and considered as cured at
6 months, there was no relapse of the osteomyelitis. This
pragmatic and simpliﬁed approach has several advantages: (i)
the infected area can be visualized and thus cannot be missed
when the specimen is drawn; (ii) the necrotic bone specimen
is assumed to have a high bacterial load that may increase
the likelihood of positive culture, even with recent antibiotic
therapy; (iii) the medical treatment can be quickly imple-
mented after the bone specimen was drawn; and (iv) the
method does not create a new wound, which is especially
important in patients with severe arteritis.
Our cohort comprised 80 consecutive patients, with most
of them having a severe osteomyelitis. Arteritis was associ-
ated with difﬁcult to treat osteomyelitis such as calcaneum
infections, which are known to have a poor prognosis [16].
Similar to other studies, we found a high frequency of multi-
resistant bacteria, especially MRSA [11,17,18]. Patients with
resistant bacteria had similar risk factors to those reported
in other studies, including previous exposure to various anti-
biotics and frequent hospitalization as a result of complicated
diabetes [11,17,18]. This makes the medical treatment of
these patients more challenging, in addition to the severity of
the disease in our population.
The present study had several limitations. First, the study
is observational and retrospective. Second, this simpliﬁed
approach can be used only in patients with a positive
probe-to-bone test and some diabetic patients may have
osteomyelitis of the foot with no wound or with a negative
probe-to-bone test. However, because the osteomyelitis is
usually the result of a neglected chronic ulcer, the rate of a
positive probe-to-bone test is high in patients with diabetic
osteomyelitis; for example, 95% of the 185 patients with
proven diabetic foot osteomyelitis in the series published
by Aragon-Sanchez et al. [11]. Third, we cannot exclude
contamination of the sample by the skin ﬂora, which may
partly explain the high rate of multiresistant bacteria.
Performing a biopsy via an infected open wound is not
recommended because of the risk of contamination by colo-
nizing ﬂora. Surgical transcutaneous bone biopsy obtained via
a normal skin area after incision has been described by
Senneville et al. [14] and is now the gold standard for micro-
biological diagnosis [5]. Although the risk of contamination
does exist with our approach, we consider the risk to be
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small for several reasons. First, careful debridement and
cleaning of the wound reduces surface contamination. Sec-
ond, our microbiological results were quite similar to those
found by Senneville et al. [14] and Aragon-Sanchez et al. [11]
who performed surgical bone biopsy and surgical resections,
respectively (Table 3). Third, all antibiotic therapy was based
on our bone sample culture results and the outcomes were
good, taking into account the severity of the osteomyelitis,
the high frequency of resistant bacteria and the presence of
peripheral arterial disease. At 6 months after antibiotic dis-
continuation, 65 patients recovered, six had died before
assessment and nine were considered as stable or failures.
However, a new episode of infection at a different site
and with pathogens distinct from the initial episode occurred
in seven patients during the 6-month follow-up period (and
six of 54 patients at 1 year). These new distinct episodes of
osteomyelitis may be explained by the fact that most of our
80 patients live in a rural, mountainous area, far from the
tertiary health care centre [19]. Furthermore, 37.5% of our
patients had a past medical history of amputation that may
increase the risk of re-ulceration and therefore re-infection
at a distinct site.
Most of our patients received an empirical antibiotic
therapy administrated by the general practitioners to treat
suspected cutaneous infection, usually without any microbio-
logical investigation. Senneville et al. [14] recommend that
patients should not receive any antibiotic therapy for 2–
4 weeks before biopsy aiming to avoid false negative results.
Indeed, some anti-microbials such as ﬂuoroquinolones or rif-
ampicin may have a prolonged release in bone that may also
affect culture results. This recommendation implies a delay in
starting deﬁnitive treatment. However, all our patients had
severe osteomyelitis with perception of a necrotic bone or
sequestra on wound exploration. Many of them had a past
history of amputation (37.5%) or osteomyelitis (50%) and a
majority (60%) had arteritis, which represents the main fac-
tor leading to amputation that is associated with infection.
Thus, for the vast majority of our diabetic population, we
osteomyelitis treatment should not be delayed. Moreover,
the bacterial load is likely to be high in sequestra or necrotic
bone, whereas the antibiotic penetration in such a bone is
weak, especially in arteritic patients. This may increase the
efﬁciency of bone culture despite previous antibiotic therapy.
This hypothesis is conﬁrmed in the study by Aragon-Sanchez
et al. [11] in which 71% of patients received antibiotics
before the surgical procedure; of 176 bone specimen with
histopathological conﬁrmation of bone infection, 20 (11%)
were negative for culture, although there was no statistical
association between prior antibiotic therapy and negative
results in culture.
In conclusion, although surgical transcutaneous bone
biopsy obtained via an incision in a normal skin area followed
by adequate antibiotic therapy should be the standard of
care for treating diabetic osteomyelitis, medical treatment
based on the results of cultures of bone sampled via the
ulcer after a careful debridement of the wound is an attrac-
tive altrenative and is associated with satisfactory outcomes.
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